Reproducibility crisis: Blame it on the antibodies
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These serum cTnI enrichment results illustrate the major benefits of functionalized NPs compared to current antibody-based approaches: (1) NPs are capable of reproducibly and effectively enriching cTnI (Supplementary Fig. 23) across all tested serum samples without the use of antibody, thus overcoming the intrinsic antibody-related limitations (vide supra)14,15,51–53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Thus, these NPs can serve as replacements to conventional immuno-based techniques to overcome the antibody-related limitations in cTnI immunoassays and potentially address the current reproducibility crisis caused by antibodies in general14–16,51,53.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Yet a recent survey found that 70% of scientists have tried and failed to reproduce results from a published experiment.1”
From Reproducibility of Quantitative Systems Pharmacology Models: Current Challenges and Future Opportunities (2019) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“However, antibodies possess many inherent limitations: batch-to-batch variation, high cost of production, poor chemical stability, and lack of proteoform-specific epitope recognition that collectively contribute to reproducibility issues [62–64].”
From Top-down proteomics: challenges, innovations, and applications in basic and clinical research (2020) · cites this paper as [63]
In the citing paper
“However, antibody-based platforms suffer from significant limitations including the batch-to-batch variability, high cost of the antibody production, and relatively low chemical stability14,15.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [14]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies
Berglund, L., Björling, E., Oksvold, P., Fagerberg, L., Asplund, A., Al-Khalili Szigyarto, C., Persson, A., Ottosson, J., Wernérus, H., Nilsson, P., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r800013-mcp200 · Cited by 672
Reproducibility: Standardize antibodies used in research
Bradbury, A., & Plückthun, A. (2015) · Nature · doi:10.1038/518027a · Cited by 647
Bordeaux, J., Welsh, A. W., Agarwal, S., Killiam, E., Baquero, M. T., Hanna, J. A., Anagnostou, V. K., & Rimm, D. L. (2010) · BioTechniques · doi:10.2144/000113382 · Cited by 589
An assessment of histone-modification antibody quality
Egelhofer, T. A., Minoda, A., Klugman, S., Lee, K., Kolasinska-Zwierz, P., Alekseyenko, A. A., Cheung, M.-S., Day, D. S., Gadel, S., Gorchakov, A. A., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1972 · Cited by 428
How reliable are G-protein-coupled receptor antibodies?
Michel, M. C., Wieland, T., & Tsujimoto, G. (2009) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-009-0395-y · Cited by 306
Prassas, I., & Diamandis, E. P. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-1078 · Cited by 31
Cited by
Items 601–700 of 816
Comprehensive Molecular Characterization of a Cisplatin-Specific Monoclonal Antibody
Ruhe, L., Ickert, S., Hochkirch, U., Hofmann, J., Beck, S., Thomale, J., & Linscheid, M. W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00575 · Cited by 4
Harnessing Anti-Idiotypic Antibody Alternatives to Advance Biotherapeutic Pharmacokinetic Assays
Johnson, M. (2020) · Bioanalysis · doi:10.4155/bio-2019-0291 · Cited by 4
The RabGAPs EPI64A and EPI64B regulate the apical structure of epithelial cells†
Miller, M. R., McDermitt, D. J., Sauvanet, C., Lombardo, A. T., Zaman, R., & Bretscher, A. P. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e21-05-0268 · Cited by 3
Development of a spermine lipid for transient antibody expression
Sui, S., Wang, H., Song, J., & Tai, W. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.117114 · Cited by 3
De novo protein design: a transformative frontier in clinical protein applications
Gao, J., Zheng, Z., Yu, X., Luo, Y., Yu, Y., & Zhang, C. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07784-0 · Cited by 3
Wenzel, E. V., Al-Halabi-Frenzel, L., Demiral, S., Frenzel, A., Gnann, D. C., Keitel, M. C.-E., Lehmler, N., Mukherjee, T., Rauls, J., Schirrmann, T., et al. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1765764 · Cited by 5
“…(Dübel, 2024), despite well-known problems with false positive or lacking reactivities (Begley and Ellis, 2012; Bradbury A. M. and Plückthun, 2015; Goodman, 2018; Bradbury A. and Plückthun, 2015) and always poorly defined contents that are “littering the field with false findings” (Baker, 2015).”
Kinetic Rate Determination via Electrophoresis along a Varying Cross-Section Microchannel
Kapil, M. A., Pan, Y., Duncombe, T. A., & Herr, A. E. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04445 · Cited by 3
Shank-Retzlaff, M. L., Abdeen, S. J., Bronsart, L. L., Cieslak, A. N., Cruse, J. K., Kinne, A. S., Mohanty, P., Parmer, E. S., Radford, S., & Bowsher, R. R. (2024) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2024.116409 · Cited by 4
La reproducibilidad de las investigaciones biomédicas: Quo vadis?
Dal‐Ré, R., Bernad, A., & Garesse, R. (2016) · Medicina Clínica · doi:10.1016/j.medcli.2015.11.029 · Cited by 4
Antibody Watch: Text mining antibody specificity from the literature
Hsu, C., Chang, C., Poopradubsil, T., Lo, A., William, K. A., Lin, K., Bandrowski, A. E., Özyurt, İ. B., Grethe, J. S., & Martone, M. E. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008967 · Cited by 3
“One of the most common antibody problems is that the antibody may not bind only to the antigen that their providers design them for, known as the problem of antibody specificity [5, 6].”
BackgroundIack, P. M., Rayêe, D., Lent, R., Ribeiro‐Resende, V. T., & Garcez, P. P. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15568 · Cited by 3
“As for mean intensity of fluorescence analyses, there has been an increasing concern for antibodies binding reliability, with many implications and biases to be considered (Baker, 2015).”
BackgroundMesowestern Blot: Simultaneous Analysis of Hundreds of Submicroliter Lysates
Zadeh, C. O., Huggins, J. R., Sarmah, D., Westbury, B. C., Interiano, W. R., Jordan, M. C., Phillips, S. A., Dodd, W. B., Meredith, W. O., Harold, N. J., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c02201 · Cited by 3
Kshirsagar, S., Islam, M. A., Reddy, A. P., & Reddy, P. H. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241310716 · Cited by 4
Computationally Designed Nanobinders as Affinity Ligands in Diagnostic and Therapeutic Applications
Jeon, J., Liu, Q. J., Woo, H., Barth, I., Choi, Y., Sang, L. J., & Lee, H. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c11289 · Cited by 3
Expression of Egr3 in mouse gonads and its localization and function in oocytes
Shin, H., Seol, D., Nam, M., Song, H., Lee, D. R., & Lim, H. J. (2016) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.16.0798 · Cited by 3
“Antibodies are often the most common culprits of problems in biological experiments due to nonspecific binding to other proteins [19].”
Soluble Molecularly Imprinted Nanorods for Homogeneous Molecular Recognition
Liang, R., Wang, T., Zhang, H., Yao, R., & Qin, W. (2018) · Frontiers in Chemistry · doi:10.3389/fchem.2018.00081 · Cited by 3
“In nature, antibodies and enzymes play vital roles in various biological processes such as molecular recognition, signal transduction, and immune response (Baker, 2015; Schwalm et al., 2016).”
BackgroundImpact of Inadequate Methods and Data Analysis on Reproducibility
Elliott, S. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.07.003 · Cited by 3
Validation of Isoform- and Mutation-Specific RAS Antibodies
Waters, A. M., & Der, C. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1190-6_5 · Cited by 3
Remmen, H. V., Freeman, W. M., Miller, B. F., Kinter, M. T., Wren, J. D., Chiao, A., Towner, R. A., Snider, T. A., Sonntag, W. E., & Richardson, A. G. (2021) · GeroScience · doi:10.1007/s11357-021-00454-7 · Cited by 3
Sekida, S.-Y., Chisaka, T., Uchiyama, J., Takemura‐Uchiyama, I., Matsuzaki, S., Niko, Y., Hadano, S., & Watanabe, S. (2023) · Bulletin of the Chemical Society of Japan · doi:10.1246/bcsj.20230200 · Cited by 3
Eckhardt, M., & Wang‐Eckhardt, L. (2015) · Molecular Human Reproduction · doi:10.1093/molehr/gav046 · Cited by 3
“Unfortunately, they also may hamper the progress of research projects because of insufficient validation, cross-reactivity with other antigens or batch-to-batch variability (Baker, 2015).”
BackgroundProduction and Purification of Antibodies Against Histone Modifications
Guillemette, B., Hammond-Martel, I., Würtele, H., & Verreault, A. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6630-1_9 · Cited by 3
Targeted Analysis of Phosphotyrosine Signaling by Multiple Reaction Monitoring Mass Spectrometry
Payne, L. S., & Huang, P. H. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7154-1_17 · Cited by 3
Experimental Planning and Execution
Mullane, K., Curtis, M. J., & Williams, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804725-5.00002-1 · Cited by 3
Molecular Markers in Bone and Soft-Tissue Tumors
Wustrack, R. L., Cooper, K., & WEBER, K. L. (2016) · JBJS Reviews · doi:10.2106/jbjs.rvw.15.00092 · Cited by 3
Retraction Note to: KDM3A confers metastasis and chemoresistance in epithelial ovarian cancer
Pa, M., Naizhaer, G., Seyiti, A., & Kuerbang, G. (2016) · Journal of Molecular Histology · doi:10.1007/s10735-016-9653-8 · Cited by 3
RetractedAFFINOMICS and the prospects for large-scale protein analyses
Landegren, U. D. (2015) · New Biotechnology · doi:10.1016/j.nbt.2015.09.006 · Cited by 3
A Practical Guide to Translating Nanomedical Products
Bawa, R. (2016) · Wiley eBooks · doi:10.1002/9783527800681.ch28 · Cited by 3
The role of mass spectrometry analysis in bacterial effector characterization
Scott, N. E., & Hartland, E. L. (2017) · Biochemical Journal · doi:10.1042/bcj20160797 · Cited by 3
A ChIP-exo screen of 887 PCRP transcription factor antibodies in human cellsPreprint
Lai, W. K. M., Mariani, L., Rothschild, G., Smith, E. R., Venters, B. J., Blanda, T. R., Kuntala, P. K., Bocklund, K., Mairose, J., Dweikat, S. N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.08.140046 · Cited by 3
Peng, W., Pronker, M. F., & Snijder, J. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.07.425675 · Cited by 3
Heterologous antigen selection of chicken single-chain variable fragments against thiamethoxam
He, J., Wang, Y., Wang, D., Yang, Y., Xue, X., Xu, T., Gu, S., & Tang, F. (2024) · Analytical Methods · doi:10.1039/d3ay01422c · Cited by 2
Abudukeremu, A., Azatibieke, G., Yimiti, G., Guan, Y., & Chen, Z. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-05132-w · Cited by 2
“This may be an important reason for poor reproducibility in biomedical research [2, 4, 6].”
Cost-Effective Method for Full-Length Sequencing of Monoclonal Antibodies from Hybridoma Cells
Döring, S., Tscheuschner, G., Flemig, S., Weller, M. G., & Konthur, Z. (2025) · Antibodies · doi:10.3390/antib14030072 · Cited by 3
“In recent years, several experiments from different publications could not be reproduced due to quality problems with monoclonal antibodies [28–30].”
Mirka, B., Ding, J., & Lapointe, F. (2025) · ACS Applied Nano Materials · doi:10.1021/acsanm.5c02527 · Cited by 2
Nilvebrant, J., Moro, C. F., Papalanis, E., Novin, M. O., Ding, H., Li, R., Oroujeni, M., Selvam, A. K., Bozóky, B., Gräslund, T., et al. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102512 · Cited by 2
“Such efforts are well in line with the current view that affinity reagents used in research and clinical diagnostics should be defined by their sequences and available as reproducible recombinant protein reagents [4,9].”
Improving the Fidelity of Replication of a Six-Letter DNA Alphabet
Kim, H.-J., Wenta, A. J., Dobrzycki, L. M., Biondi, E., & Benner, S. A. (2025) · ACS Chemical Biology · doi:10.1021/acschembio.5c00724 · Cited by 3
Techniques to study chimerism at the tissue level in humanized mice
Cox, A., Banerjee, E., Verrelle, J., Willis, E., Assenmacher, C., Finesso, G., Tarrant, J. C., & Radaelli, E. (2025) · Veterinary Pathology · doi:10.1177/03009858251386916 · Cited by 2
Makkar, S., Nehra, K., Singh, A., & Annepu, S. K. (2025) · Scientific Reports · doi:10.1038/s41598-025-27701-7 · Cited by 3
“These in vitro observations, however, are limited to cell culture models and must be interpreted with caution, as they do not account for the complex pharmacokinetic and pharmacodynamic factors present in vivo 21,22 .”
Dynamic Interaction: Synthetic Biology and Cell-Free Biosensors Drive Each Other Forward
Liu, S., Ma, B., Chi, H., Lu, Y., Abe, H., Wang, G., Guo, K., Jiang, C., Zhang, C., & Li, C. (2025) · ACS Nano · doi:10.1021/acsnano.5c12137 · Cited by 2
An aptamer-CRISPR/Cas12a biosensor for rapid and sensitive detection of florfenicol
Huang, Y. H., ZHAO, Z., Li, J., Wang, X., QU, H., & Zheng, Y. (2026) · Analytical Methods · doi:10.1039/d5ay01903f · Cited by 2
Low-affinity binding of anti-B7-H3 clone MJ18 to murine B7-H3 fails to induce tumor regression
Gulyás, D., Nammor, T., Frizzell, J. K., Lavoie, R. R., Geng, L., Markovic, S. N., & Lucien, F. (2026) · Scientific Reports · doi:10.1038/s41598-026-40628-x · Cited by 2
“Unfortunately, the lack of specificity of antibodies used in research is not new and it has already been under the spotlight 49,50 .”
Bao, X., Jiang, Y., Hermes, B., Sanai, N., & Li, J. (2026) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdag070 · Cited by 2
Zou, R., Guo, Y., Wang, Z., Yang, P., Liu, C., Liu, Y., Zhu, G., & Guo, Y. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c06597 · Cited by 2
Lan, L., Xue, G., Song, Q., Wu, R., Li, X., Yuan, Y., Zhang, M., Shen, Z., & Xue, C. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c00143 · Cited by 2
Antibody-trapping presents a widespread pitfall for microscopy and genomics in the nucleus
Chudzik, K., Sato, Y., Yan, X., Ullrich, S., Trakarnphornsombat, W., Schermelleh, L., Fudenberg, G., Kimurâ, H., Robson, M. I., & Solovei, I. V. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag615 · Cited by 5
“The biomedical sciences struggle with a “reproducibility crisis,” which has been in part attributed to the unreliable performance of Ab-based assays [ 76–78 ].”
Biddle, M., Cooper, J., Blades, K., Ruddy, D., Krockow, E. M., & Virk, H. S. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003984 · Cited by 2
Developing Potential Candidates of Preclinical Preeclampsia
Founds, S. A., Zeng, X., Lykins, D. L., & Roberts, J. M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126023 · Cited by 2
“The research community’s access to commercially-produced reliable and valid antibodies has been an issue for due to variability among lots of the same antibody, nonspecific binding of extra proteins, and lack of standards for commercial production of antibodies [40,41].”
BackgroundAlm, T., Lundberg, E. K., & Uhlén, M. (2016) · EuPA Open Proteomics · doi:10.1016/j.euprot.2016.01.002 · Cited by 2
Crosby, K., Wood, A. W., Simendinger, J., Grange, C., Carr, L., Costa-Grant, K., Roller, C. J., & Polakiewicz, R. D. (2020) · Journal of Histotechnology · doi:10.1080/01478885.2020.1847012 · Cited by 2
Anselm, V., Steinhilber, A., Sommersdorf, C., & Poetz, O. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1186-9_17 · Cited by 2
Kvivik, I., Jonsson, G., Omdal, R., & Brede, C. (2021) · Pharmaceuticals · doi:10.3390/ph14060537 · Cited by 2
“Even though immunoassays for HMGB1, such as ELISA, are highly sensitive and have high throughput, they are prone to errors caused by the presence of HMGB1 autoantibodies, cross-reactivity interference, or competitive binding of other proteins present in blood [12,13].”
BackgroundElevated CD9 expression as a potential biomarker for diagnosis of Bernard-Soulier syndrome
Sharifi, M. J., Vakili, E., Ilkhanipoor, H., Zekavat, O. R., & Bordbar, M. (2022) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000001117 · Cited by 2
Feauto, J. A., Davis, A., Delhaye, R., Abdeen, S. J., Gill, H. N., Colwell, J. E., Chiappetta, M. F., Clor, E. E., & Bowsher, R. R. (2022) · Bioanalysis · doi:10.4155/bio-2022-0096 · Cited by 2
Xu, W., Chen, H., Li, Y., Cheng, H., Deng, Y., Zheng, P., Li, J., Yang, L., He, S., Ma, D., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c03637 · Cited by 2
Proteomics applications in next generation induced pluripotent stem cell models
Manda, V., Pavelka, J., & Lau, E. (2024) · Expert Review of Proteomics · doi:10.1080/14789450.2024.2334033 · Cited by 2
Luo, Y. K., Yin, J., Cao, J., Xie, B., Zhang, F., Ouyang, S., Zhou, J., Tan, Y., & Xiong, W. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.11.57 · Cited by 3
“44,45 In our study, the following in vitro functional analysis further confirmed the binding affinity and efficacy of CD34 Apt-coupled Tocilizumab microspheres in mitigating TGF-β - induced changes in CD34 + orbital fibroblasts.”
Lectins – valuable bioligands towards sustainable clinical sensing?
Silva, M. L. S. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120750 · Cited by 2
Herlan, L., Schulz, A. M., Schulte, L., Schulz, H., Hübner, N., & Kreutz, R. H. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12462 · Cited by 3
Birabaharan, J., & Ascoli, C. A. (2015) · Genetic Engineering & Biotechnology News · doi:10.1089/gen.35.14.03 · Cited by 2
Muratore, K. A., Grundhofer, H. M., & Arriaga, E. A. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03270 · Cited by 3
A commercial ARHGEF17/TEM4 antibody cross-reacts with Nuclear Mitotic Apparatus protein 1 (NuMA)
Prifti, D. K., Lauzier, A., & Elowe, S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0268848 · Cited by 2
“The validation of antibodies has unfortunately significantly faltered compared to their production, resulting in only very basic and non-quantitative verification, followed by the consequent flaws in the reliability of many of the available reagents (Baker,2020, 2015).”
BackgroundYunusova, A., Smirnov, A. V., Pristyazhnyuk, I. E., Шнайдер, Т. А., Maltseva, E., Afonnikova, S. D., Gusev, O., & Баттулин, Н. Р. (2024) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-24-16 · Cited by 2
Mass spectrometry-based approaches for quality control and quantification of monoclonal antibodies
Severino, V. (2016) · Materials and Methods · doi:10.13070/mm.en.6.1533 · Cited by 2
Systems Biology: Methods and Applications
Titz, B., Knorr, A., Sewer, A., Martin, F. P., Ivanov, N. V., Talikka, M., Suarez, I. G., Peitsch, M. C., & Hoeng, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12333-9 · Cited by 2
Varga, A., Kumar, J. D., Simpson, A. W. M., Dodd, S., Hegyi, P. J., Dockray, G. J., & Varró, A. (2017) · Physiological Reports · doi:10.14814/phy2.13394 · Cited by 3
“There are well-known issues regarding interpretation of immunocytochemical studies with antibodies to G-protein coupled receptors (GPCRs) (Baker 2015).”
BackgroundEvaluation and validation of commercial antibodies for the detection of Shb
Vanli, G., Cuesta-Marbán, Á., & Widmann, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188311 · Cited by 2
Use, Applications and Mechanisms of Intracellular Actions of Camelid VHHs
Steels, A., Bertier, L., & Gettemans, J. (2018) · InTech eBooks · doi:10.5772/intechopen.70495 · Cited by 4
Localization of SUMO-modified Proteins Using Fluorescent Sumo-trapping Proteins
Yin, R. M., Harvey, C., Shakes, D. C., & Kerscher, O. (2019) · Journal of Visualized Experiments · doi:10.3791/59576 · Cited by 2
Analytical Validation of Quantitative Pharmacodynamic Methods used in Clinical Cancer Studies
Pluim, D., & Beijnen, J. H. (2021) · International Archives of Clinical Pharmacology · doi:10.23937/2572-3987.1510026 · Cited by 2
Berman, J. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814393-3.00008-1 · Cited by 2
The 3rd Antibody Validation meeting: Bath UK 20-21st September 2018
Goodman, S. L. (2018) · F1000Research · doi:10.12688/f1000research.17645.1 · Cited by 2
Rigor, Reproducibility, and Responsibility: A Quantum of Solace
Turner, J. R. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.03.006 · Cited by 2
Oyler, J. M., Maistros, K. J., Oyler, B. L., & Kilgour, D. P. A. (2020) · Wiley eBooks · doi:10.1002/9780470027318.a0408.pub3 · Cited by 2
Whiteaker, J. R., Zhao, L., Schoenherr, R. M., Huang, D., Kennedy, J. J., Ivey, R. G., Lin, C., Lorentzen, T. D., Colantonio, S., Caceres, T. W., et al. (2024) · Scientific Data · doi:10.1038/s41597-024-03467-x · Cited by 3
“Traditional technologies, like Western blot or immunohistochemistry (IHC), rely on highly characterized, monospecific antibodies, which can be susceptible to interferences and/or cross-reactivity 7 .”
BackgroundTaatjes, D. J., & Roth, J. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02401-5 · Cited by 2
“A very large body of literature has evolved over the years discussing the issues around antibody validation to ensure the accuracy of reported immunostaining results (see, for instance, Pra-didarcheep et al. 2008; Couchman 2009; Saper 2009; Baker 2015).”
Data‐driven evaluation of suitable immunogens for improved antibody selection
Waury, K., Kvartsberg, H., Zetterberg, H., Blennow, K., Teunissen, C. E., & Abeln, S. (2025) · Protein Science · doi:10.1002/pro.70100 · Cited by 1
“Choosing the most appropriate and reliable antibody for the intended application is an important step in overcoming the current reproducibility and reliability issues of research using antibody technologies due to hindered or unspecific antibody binding (Baker, 2015).”
DECODE enables high-throughput mapping of antibody epitopes at single amino acid resolution
Matsumoto, K., Harada, S. Y., Yoshida, S. Y., Narumi, R., Mitani, T. T., Yada, S., Sato, A., Morii, E., Shimizu, Y., & Ueda, H. R. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3002707 · Cited by 1
Qi, M., Xia, N., Wang, X., Wang, X., Chen, H., Lv, D., & Cao, Y. W. (2025) · Biosensors · doi:10.3390/bios15110706 · Cited by 1
“…amount of published research based on antibodies cannot be reproduced by antibodies from the same antibody manufacturer in other experiments because of the inaccurate information of antibodies provided by manufacturers and the instability of antibodies during storage and transport [12,13].”
Nepveu-Traversy, M.-É., Hassanzadeh, M., Bruneau‐Cossette, L., Besserer‐Offroy, É., Brouillette, R. L., Morissette, S., Traboulsi, H., Kirby, K., Murza, A., Longpré, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66030-1 · Cited by 1
Methods for Determining Saxitoxin and Ricin: A Review
Kovalenko, I. I., Braun, А. V., Grigoryev, A., Rybalchenko, I. V., & Fateenkov, V. N. (2025) · Journal of Analytical Chemistry · doi:10.1134/s106193482570114x · Cited by 1
Protein binding assessment of immobilized nanobody using interferometric nanoporous platform
Law, C. S., Revink, J., Lee, J. W., Wang, J., Abell, A. D., Whelan, F., & Santos, A. (2026) · Open Research (University of Surrey) · doi:10.1002/viw.20250182 · Cited by 1
Metabolomics identifies chenodeoxycholic acid as a protective factor in diabetic foot ulcers
Li, Y., Guo, R., Lv, L., Jiang, T., Zhang, C., Chang, J., Hu, K., Peng, H., Chen, L., Chen, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1754743 · Cited by 1
“Future validation of the clinical value of CDCA necessitates multicenter, large-scale cohort studies (36).”
Exploring the physical principles of cell collective behaviors using robot swarms
Pan, M., Long, M., Liu, L., & Yang, Y. (2026) · Biomimetic Intelligence and Robotics · doi:10.1016/j.birob.2026.100335 · Cited by 1
Gray, A. C., & Gough Kevin, C. (2026) · Alternatives to Laboratory Animals · doi:10.1177/02611929261455318 · Cited by 2
Barile, V., Kuzikov, M., Cui, W., Ianevski, A., Iannelli, F., Roca, M. S., Reinshagen, J., Axelsson, H., Leone, A., Jensen, A. J., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119575 · Cited by 1
Actionable solutions to address antibody validation failures
Blades, K., Biddle, M., Froud, R., Krockow, E. M., & Virk, H. S. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003981 · Cited by 2
Modelling Molecular Mechanisms of Cancer Pathogenesis: Virtual Patients, Real Opportunities
Lehrach, H., Kessler, T., Ogilvie, L. A., Schütte, M., & Wierling, C. (2017) · Springer eBooks · doi:10.1007/978-3-319-53661-3_16 · Cited by 1
A cardinal sin when researching neuropsin/KLK8: Thou shalt validate antibodies
Lahiri, D. K., Konar, A., Thakur, M. K., & Maloney, B. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.12.016 · Cited by 1
“These certainly could be purely technical deficiencies, but the matter of antibody validation can no longer be simply taken as a matter of course [4].”
Reproducibility of biomedical research: Quo vadis?
Dal‐Ré, R., Bernad, A., & Garesse, R. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.06.029 · Cited by 1
Targeted Mass Spectrometry-Based Proteomics Method to Quantify Placental Extracellular Vesicles
Lai, A., Palma, C., Salas-Burgos, A., Carrión, F., & Salomón, C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2341-1_6 · Cited by 1
Basics of affinity and its importance in designing molecularly imprinted polymers
Köse, K., & Uzun, L. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15431-7.00015-5 · Cited by 1
Vokes, J. R., Gedye, K. R., Lovett, A. L., de Kantzow, M. C., Shan, R., Steel, C. M., & Sykes, B. W. (2024) · Animals · doi:10.3390/ani14202937 · Cited by 1
Mendez, Q. M., Thota, S. S., Oliveira, J., Crary, H. J., Saha, S., Jones, K. S., Pérez, L. P. E., Acca, F. E., Chapados, C. D., Driscoll, H. A., et al. (2025) · New Biotechnology · doi:10.1016/j.nbt.2025.05.007 · Cited by 1
A Western Blot and Immunoprecipitation Assay to Verify Antibody Specificity
Bonnette, S. G. (2015) · BioTechniques · doi:10.2144/000114332 · Cited by 1
The burgeoning antibody landscape
Huston, J. S. (2016) · Protein Engineering Design and Selection · doi:10.1093/protein/gzw044 · Cited by 1
“Reference may also be made to other recent reports (Baker, 2015; Freedman et al., 2016).”
ResultRe‐visiting F c‐receptor blocking maneuvers in man
Smith, P. J., & Chattopadhyay, P. K. (2016) · Cytometry Part A · doi:10.1002/cyto.a.22998 · Cited by 1
“Not surprisingly, there have been repeated calls to deal with this situation (7,8,10,11).”
BackgroundTu, B., Tieman, B. C., Moore, J. A., Pan, Y., & Muerhoff, A. S. (2017) · Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · doi:10.1089/mab.2017.0009 · Cited by 1
Asphyxia Diagnosis: An Example of Translational Precision Medicine
Lüddecke, J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805364-5.00014-7 · Cited by 1
Metadata
- Authors
- Baker, M.
- Corresponding author
- Baker, Monya
- Venue
- Nature
- Published
- 2015-05-19
- Volume
- 521
- Issue
- 7552
- Pages
- 274-276
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1592986776
- Cited by
- 830
- References
- 7
- Citations by year
- 2026: 55 · 2025: 58 · 2024: 56 · 2023: 57 · 2022: 67 · 2021: 68 · 2020: 78 · 2019: 75 · 2018: 87 · 2017: 93 · 2016: 83 · 2015: 51
- Type
- other
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Keywords
- replication crisis, immunoglobulins, antibody validation, scientific rigor, research integrity
- MeSH terms
- Antibodies, Antibody Specificity, Cross Reactions, Humans, Indicators and Reagents, Membrane Proteins, Quality Control, Reagent Kits, Diagnostic, Reproducibility of Results, Artifacts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.